Teva Pharmaceutical Industries Ltd. (TEVA)

6.97
0.24 3.57
NYSE : Health Technology
Prev Close 6.73
Open 6.70
Day Low/High 6.62 / 7.08
52 Wk Low/High 6.07 / 23.97
Volume 13.30M
Avg Volume 20.22M
Exchange NYSE
Shares Outstanding 1.09B
Market Cap 7.42B
EPS -2.30
P/E Ratio N/A
Div & Yield N.A. (N.A)
Teva Announces Upsizing And Successful Pricing Of $4.5 Billion Of Senior Notes

Teva Announces Upsizing And Successful Pricing Of $4.5 Billion Of Senior Notes

Teva Pharmaceutical Industries Limited (NYSE and TASE: TEVA) ("Teva") announced today that it successfully priced the offering of $4.

Study: Over-the-Counter Meds More Effective For Chronic Back Pain Than Opioids

Study: Over-the-Counter Meds More Effective For Chronic Back Pain Than Opioids

A study published by the Journal of the American Medical Association shows OTC drugs were more effective in cutting pain for chronic back pain and osteoarthritis hip and knee patients than opioids.

Mylan Breaks Out Amid Generic Malaise; Target Shorts Rejoice -- ICYMI

Mylan Breaks Out Amid Generic Malaise; Target Shorts Rejoice -- ICYMI

Here's what you need to know now for Tuesday, March 6.

Mylan Shares Surge as Analyst Says It's Poised to Gain Share From Rivals

Mylan Shares Surge as Analyst Says It's Poised to Gain Share From Rivals

Morgan Stanley analyst David Risinger is upbeat about the drugmaker's generic drug growth prospects in the U.S.

4 Smart Money Stock Picks

4 Smart Money Stock Picks

Sometimes finding fresh investing inspiration can be a challenge, but if you examine the latest hedge fund moves, you can find insights from some of the world's savviest investors.

Teva Announces Launch Of Offering Of Senior Notes

Teva Announces Launch Of Offering Of Senior Notes

Teva Pharmaceutical Industries Limited (NYSE and TASE: TEVA) ("Teva") announced today that its special purpose finance subsidiary, (i) Teva Pharmaceutical Finance Netherlands II B.

Attorney General Sessions Announces New Federal Opioids Taskforce

Attorney General Sessions Announces New Federal Opioids Taskforce

After months of inaction by the federal government on the crisis regarding opioid abuse, Attorney General Jeff Sessions announced the creation of a task force charged with looking at how drug makers and distributors operate.

Allergan Handed Patent Defeat Over Restasis

Allergan Handed Patent Defeat Over Restasis

Allergan's losing streak in a bid to stash patent rights protecting cash cow Restasis remains intact as the U.S. Patent Trial and Appeal Board rejects a move to dismiss a challenge brought by a trio of pharma companies.

Jim Cramer: The Government Should Admit It Goofed With These Crazy Instruments

Jim Cramer: The Government Should Admit It Goofed With These Crazy Instruments

We used to think of what's in the public's interest when it comes to securities.

Teva Announces Exclusive Launch Of Two Strengths Of A Generic Version Of Solodyn® In The United States

Teva Announces Exclusive Launch Of Two Strengths Of A Generic Version Of Solodyn® In The United States

Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the exclusive launch of two strengths of a generic version of Solodyn ®1 (minocycline HCl) Extended Release Tablets, 65 and 115 mg, in the U.

Novartis May Sell U.S. Generic Pill Business Amid Industry Struggles

Novartis May Sell U.S. Generic Pill Business Amid Industry Struggles

The Swiss pharmaceutical firm's U.S. generic pill business could attract as much as $1.6 billion, Reuters reported.

Five-Day Winning Streak in Stocks Expected to Continue

Five-Day Winning Streak in Stocks Expected to Continue

On Thursday alone, we experience both free-fall, as well as a raucous rally.

Dow Jumps Over 300 Points, Posting Its Fifth Straight Day of Gains

Dow Jumps Over 300 Points, Posting Its Fifth Straight Day of Gains

The Dow, S&P 500 and Nasdaq all finish higher on Thursday.

Stock Markets Around the World Are Soaring Again

Stock Markets Around the World Are Soaring Again

Japanese, Hong Kong and European markets continue Wednesday's Wall Street rally.

Jim Cramer: The SEC Should Admit It Goofed With These Crazy Instruments

Jim Cramer: The SEC Should Admit It Goofed With These Crazy Instruments

We used to think of what's in the public's interest when it comes to securities.

GM, Teva, Facebook and Other New Jana Partners Positions

GM, Teva, Facebook and Other New Jana Partners Positions

The insurgent manager that helped engineer the Amazon-Whole Foods combination just offered up a window into his latest allocations, any of which could soon become campaigns. Both Jana Partners and Warren Buffett's Berkshire Hathaway Inc. reported new positions in Teva

Teva Shares Pop After-Hours on News of Berkshire Investment

Teva Shares Pop After-Hours on News of Berkshire Investment

Berkshire Hathaway purchased 18.9 million shares of the drugmaker, according to its 13F filing.

Clearly, Warren Buffett Loves Apple's Stock

Clearly, Warren Buffett Loves Apple's Stock

Warren Buffett continues to eat up Apple's stock. He also has bought a stake in struggling generics drug maker Teva.

Teva Shares Fall as FDA OKs Another Generic Version of Multiple Sclerosis Drug

Teva Shares Fall as FDA OKs Another Generic Version of Multiple Sclerosis Drug

This is the second generic Copaxone 40 mg/mL greenlighted by the U.S. Food and Drug Administration.

Dow, S&P 500 and Nasdaq Finish Higher, Posting Third Consecutive Day of Gains

Dow, S&P 500 and Nasdaq Finish Higher, Posting Third Consecutive Day of Gains

Stocks ended higher on Tuesday.

Purdue Pharma to Downplay Opioids, Dump 50% of Sales Staff

Purdue Pharma to Downplay Opioids, Dump 50% of Sales Staff

As lawsuits tied to the opioid crisis keep piling up, Purdue Pharma is discontinuing direct sales calls to doctors. Will other opioid makers follow suit?

QVAR® RediHaler™ Product Image (Photo: Business Wire)

QVAR® RediHaler™ Product Image (Photo: Business Wire)

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that QVAR ® RediHaler ™ (beclomethasone dipropionate HFA) Inhalation Aerosol is now commercially available to patients in both 40 mcg and...

Generic Drug Makers Hurt By Latest Federal Government Budget

Generic Drug Makers Hurt By Latest Federal Government Budget

The Creating and Restoring Equal Access to Equivalent Samples Act, a measure aimed at making it easier for generic drug companies to research name brand drugs, was left out of the final budget.

Teva Nailed With S&P Downgrade

Teva Nailed With S&P Downgrade

The downgrade to BB from BBB- comes as the drugmaker continues to face challenges such as a competitive generic drug market in the U.S.

Teva Announces Launch Of A Generic Version Of Syprine® In The United States

Teva Announces Launch Of A Generic Version Of Syprine® In The United States

Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of generic version of Syprine ®1 (trientine hydrochloride) capsules, 250 mg, in the U.

Teva Shares Tank On Weak Outlook

Teva Shares Tank On Weak Outlook

The Israel-based drug maker reported fourth-quarter numbers that topped analysts' expectations, but its outlook came in below estimates.

Why Investors Shouldn't Worry About Trump's Tough Talk on Drug Prices

Why Investors Shouldn't Worry About Trump's Tough Talk on Drug Prices

While Donald Trump's tweets can shake up pharmaceutical stocks, history suggests that investors have little to fear from the president's drug pricing rhetoric.

What's Behind the Hound of Hades' Stock Market Rampage

What's Behind the Hound of Hades' Stock Market Rampage

The free market is going to take back control of interest rates.

Teva Reports 2017 Full Year And Fourth Quarter Financial Results

Teva Reports 2017 Full Year And Fourth Quarter Financial Results

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) today reported results for the year and the quarter ended December 31, 2017.

This Is the Best Advice We Can Give After the Dow Jones Industrial Average Crash

This Is the Best Advice We Can Give After the Dow Jones Industrial Average Crash

The stock market continues to be under considerable pressure. Here is one thing not to do right now amidst the carnage.

TheStreet Quant Rating: D (Sell)